- Home
- ABBV vs GE Comparison
ABBV vs GE Comparison
Compare ABBV & GE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABBV
- GE
- Stock Information
- Founded
- ABBV 2012
- GE 1892
- Country
- ABBV United States
- GE United States
- Employees
- ABBV N/A
- GE N/A
- Industry
- ABBV Biotechnology: Pharmaceutical Preparations
- GE Consumer Electronics/Appliances
- Sector
- ABBV Health Care
- GE Technology
- Exchange
- ABBV Nasdaq
- GE Nasdaq
- Market Cap
- ABBV 365.1B
- GE 299.3B
- IPO Year
- ABBV N/A
- GE N/A
- Fundamental
- Price
- ABBV $220.78
- GE $289.62
- Analyst Decision
- ABBV Buy
- GE Strong Buy
- Analyst Count
- ABBV 23
- GE 10
- Target Price
- ABBV $224.41
- GE $257.50
- AVG Volume (30 Days)
- ABBV 4.5M
- GE 4.1M
- Earning Date
- ABBV 10-29-2025
- GE 10-21-2025
- Dividend Yield
- ABBV 2.98%
- GE 0.50%
- EPS Growth
- ABBV N/A
- GE 69.20
- EPS
- ABBV 2.10
- GE 7.17
- Revenue
- ABBV $58,328,000,000.00
- GE $41,611,000,000.00
- Revenue This Year
- ABBV $9.86
- GE $8.79
- Revenue Next Year
- ABBV $8.90
- GE $10.85
- P/E Ratio
- ABBV $104.79
- GE $40.45
- Revenue Growth
- ABBV 6.05
- GE 13.06
- 52 Week Low
- ABBV $163.81
- GE $159.36
- 52 Week High
- ABBV $221.77
- GE $294.74
- Technical
- Relative Strength Index (RSI)
- ABBV 70.95
- GE 66.15
- Support Level
- ABBV $214.31
- GE $273.30
- Resistance Level
- ABBV $221.77
- GE $294.74
- Average True Range (ATR)
- ABBV 3.29
- GE 6.08
- MACD
- ABBV 0.27
- GE 1.16
- Stochastic Oscillator
- ABBV 93.92
- GE 80.85
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
About GE General Electric Company
GE Aerospace is the global leader in designing, manufacturing, and servicing commercial aircraft engines, along with partner Safran in their CFM joint venture. With its massive global installed base of nearly 70,000 commercial and military engines, GE Aerospace earns most of its profits on recurring service revenue of that equipment, which operates for decades. GE Aerospace is the remaining core business of the company formed in 1892 with historical ties to American inventor Thomas Edison; that company became a storied conglomerate with peak revenue of $130 billion in 2000 until GE spun off its appliance, finance, healthcare, and wind and power businesses between 2016 and 2024.